Andra AP fonden Cuts Position in Healthpeak Properties, Inc. $DOC

Andra AP fonden decreased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 13.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 724,300 shares of the real estate investment trust’s stock after selling 112,200 shares during the quarter. Andra AP fonden’s holdings in Healthpeak Properties were worth $13,870,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Mather Group LLC. purchased a new stake in Healthpeak Properties in the 3rd quarter valued at $25,000. City Holding Co. acquired a new position in shares of Healthpeak Properties during the 3rd quarter valued at about $26,000. Rexford Capital Inc. purchased a new stake in shares of Healthpeak Properties in the second quarter valued at about $28,000. Sound Income Strategies LLC acquired a new stake in Healthpeak Properties during the third quarter worth about $28,000. Finally, Elevation Point Wealth Partners LLC acquired a new stake in Healthpeak Properties during the second quarter worth about $32,000. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $17.67 on Friday. Healthpeak Properties, Inc. has a 52 week low of $15.71 and a 52 week high of $21.28. The company has a fifty day simple moving average of $16.93 and a two-hundred day simple moving average of $17.56. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21. The company has a market cap of $12.28 billion, a price-to-earnings ratio of 176.71, a price-to-earnings-growth ratio of 9.37 and a beta of 1.12.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, topping the consensus estimate of $0.45 by $0.02. The firm had revenue of $719.40 million during the quarter, compared to analysts’ expectations of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.Healthpeak Properties’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.1017 dividend. This represents a c) annualized dividend and a yield of 6.9%. The ex-dividend date of this dividend is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio is 1,220.00%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on DOC. The Goldman Sachs Group started coverage on shares of Healthpeak Properties in a research note on Friday, January 9th. They issued a “neutral” rating and a $17.00 price target for the company. Robert W. Baird lowered their price objective on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research report on Wednesday, November 12th. Jefferies Financial Group cut Healthpeak Properties from a “buy” rating to a “hold” rating and cut their target price for the stock from $21.00 to $17.00 in a research note on Monday, December 15th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Finally, Cantor Fitzgerald set a $17.00 price target on Healthpeak Properties in a report on Monday, January 5th. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Hold” and an average price target of $19.42.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.